Cost-Minimization and Budget Impact Analysis of Rituximab SC VS Rituximab IV for Non-Hodgkin’s Lymphoma (NHLs) in Greece

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Cost-Minimization and Budget Impact Analysis of Rituximab SC VS Rituximab IV for Non-Hodgkin’s Lymphoma (NHLs) in Greece"
written by Dionysis Kyriopoulos, Vasiliki Tsiantou, Labrini Papageorgiou, Fani Theodoropoulou, Kostas Athanasakis,
published by Journal of Cancer Therapy, Vol.8 No.8, 2017

has been cited by the following article(s):

[1]	Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements
	2021

[2]	Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics
	2020

[3]	SAĞLIK SEKTÖRÜNDE BÜTÇE ETKİ ANALİZİ
	2018

[4]	Sağlık Sektöründe Bütçe Etki Analizi
	2018

[5]	Injection technique 2: administering drugs via the subcutaneous route
	Â Nursing TimesÂ [online], 2018

Follow SCIRP